Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

164,701-164,760 of 319,975

filter-aware
20
Includes specific legacy credit issues and historical performance data from 2016 to Q1 2021.Southern States Bancshares | IPO Presentation Deck | 27 slides · Southern States Bancshares
Pitch deck Investment bank 1 hit
21
Includes a map of potential targets and a breakdown of opportunities by state.Southern States Bancshares | IPO Presentation Deck | 27 slides · Southern States Bancshares
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
22
Southern States Bancshares | IPO Presentation Deck | 27 slidesSouthern States Bancshares | IPO Presentation Deck | 27 slides · Southern States Bancshares
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
23
Southern States Bancshares | IPO Presentation Deck | 27 slidesSouthern States Bancshares | IPO Presentation Deck | 27 slides · Southern States Bancshares
Pitch deck Investment bank 1 hit
24
Includes footnotes explaining specific accounting treatments and calculation methodologies.Southern States Bancshares | IPO Presentation Deck | 27 slides · Southern States Bancshares
Pitch deck Investment bank 1 hit
25
This is a standard financial disclosure slide found in investor presentations to reconcile non-GAAP metrics.Southern States Bancshares | IPO Presentation Deck | 27 slides · Southern States Bancshares
Pitch deck Investment bank 1 hit
26
This is a standard financial appendix slide providing transparency into non-GAAP metrics.Southern States Bancshares | IPO Presentation Deck | 27 slides · Southern States Bancshares
Pitch deck Investment bank 1 hit
27
The slide provides a detailed breakdown of adjustments to GAAP figures to arrive at non-GAAP metrics.Southern States Bancshares | IPO Presentation Deck | 27 slides · Southern States Bancshares
Pitch deck Investment bank 1 hit
01
Slide 1
Synchrony Financial | Results Presentation Deck | 16 slidesSynchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What Is1 hit
02
Synchrony Financial | Results Presentation Deck | 16 slidesSynchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What Is1 hit
03
Synchrony Financial | Results Presentation Deck | 16 slidesSynchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What Is1 hit
04
Includes logos of partners, bar charts for consumer performance, and big numbers for digital metrics.Synchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What Is1 hit
05
The slide uses a 'Grow the Core' vs 'Expand' framework to illustrate strategic focus.Synchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What IsLoop · Aha Moment1 hit
06
The table shows financial performance metrics including interest income, expenses, and earnings per share.Synchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What IsLoop · Aha Moment1 hit
07
Synchrony Financial | Results Presentation Deck | 16 slidesSynchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What IsLoop · Aha Moment1 hit
08
The slide uses a grouped bar chart format integrated with a data table for each business segment.Synchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What IsLoop · Aha Moment1 hit
09
The slide uses a waterfall-style bridge table to explain the change in NIM from 2Q'20 to 2Q'21.Synchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What IsLoop · Aha Moment1 hit
10
Each chart displays both absolute dollar amounts (bars) and percentage rates (line).Synchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
11
Synchrony Financial | Results Presentation Deck | 16 slidesSynchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
12
Includes non-GAAP reconciliation note at the bottom.Synchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
13
Synchrony Financial | Results Presentation Deck | 16 slidesSynchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
14
Synchrony Financial | Results Presentation Deck | 16 slidesSynchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · New Bliss1 hit
15
Synchrony Financial | Results Presentation Deck | 16 slidesSynchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · New Bliss1 hit
16
The table reconciles GAAP figures to non-GAAP 'fully phased-in' CECL figures.Synchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations Beat · New Bliss1 hit
01
Slide 1
Features a metaphorical image of a person on a cliff edge, aligning with the 'Scaling New Heights' theme.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
02
This is a standard legal slide found in IPO or investor pitch decks.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
03
Standard IPO deal terms table.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
04
The slide is split into two sections: Leadership (left) and Board of Directors (right).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Team1 hit
05
Tenaya Therapeutics | IPO Presentation Deck | 36 slidesTenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
06
The slide uses a split-screen layout with text on the left and a family photo on the right, emphasizing the human impact of the company's mission.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
07
Uses a central emotional photo of a patient to anchor the 'Why We Do What We Do' aspect.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Why Now1 hit
08
The slide uses a stylized mountain/heart-shaped diagram to organize company pillars.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
09
The slide uses an infinity loop diagram to represent the interconnected nature of the three platforms.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
10
The slide uses a bottom-up flow to connect capabilities to strategic outcomes (Speed, Safety, Cost, Quality, Efficacy).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
11
The slide uses a Gantt-style visualization to show the development status of multiple drug candidates.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
12
Tenaya Therapeutics | IPO Presentation Deck | 36 slidesTenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
13
The slide uses a split-screen layout to contrast the disease state (pathophysiology) with the therapeutic intervention (product concept).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product1 hit
14
Includes bar chart, line chart, and Kaplan-Meier survival curve.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · ProductLoop · Hypothesis Test1 hit
15
The slide uses bar charts with individual data points to demonstrate efficacy across three distinct physiological metrics.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product1 hit
16
The slide uses a three-column layout to present histological, VCN (vector copy number), and protein expression data.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product1 hit
17
The slide uses two distinct charts to show tissue specificity (bar chart) and functional efficacy (line chart with error bars).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product1 hit
18
The slide uses a process flow diagram to illustrate the scaling of manufacturing capacity.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product1 hit
19
The slide uses a two-column layout to contrast past achievements (Progress) with future goals (Next Steps).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Loop · Quick Win Big Bet1 hit
20
Tenaya Therapeutics | IPO Presentation Deck | 36 slidesTenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
21
Includes anatomical pathology image and molecular structure diagram of desmosomes.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
22
Slide shows three distinct charts: a line chart for RV area, a bar chart for ejection fraction, and a Kaplan-Meier survival curve.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
23
The slide compares WT, untreated PKP2-cKO (HBSS), and treated PKP2-cKO (AAV:mPKP2) using both a bar chart of arrhythmia scores and representative ECG traces.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
24
The slide uses a combination of a bar chart for transduction ratios and a scatter plot for ventricular specificity to validate the efficacy of the TNC-CM series capsids.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
25
Tenaya Therapeutics | IPO Presentation Deck | 36 slidesTenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
26
Includes a biological mechanism diagram showing how HDAC6 inhibitors target multiple pathways leading to diastolic dysfunction and HFpEF.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
27
The slide outlines a proprietary R&D pipeline for identifying and validating drug targets using patient-derived cells and machine learning.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
28
The slide presents four bar charts comparing Control, Vehicle (disease model), and TYA-11631 (treatment) groups across four physiological metrics.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
29
The slide presents three distinct charts comparing Control, Vehicle-treated HFpEF, and TYA-11631-treated HFpEF groups.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
30
The slide presents three distinct sets of experimental results: glucose tolerance test, insulin sensitivity test, and inflammatory marker expression (Tgfb1, IL-6, IL-10).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
31
The slide uses a bar chart to show selectivity and a dose-response curve to show safety (thrombocytopenia risk).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
32
The slide uses a two-column layout to contrast past achievements (Progress) with future goals (Next Steps).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
33
Tenaya Therapeutics | IPO Presentation Deck | 36 slidesTenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
34
Includes a biological mechanism diagram and a line chart showing Ejection Fraction improvement in murine models.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
35
The slide uses a three-column layout: Disease Overview, Product Concept, and In Vivo Data.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
36
The slide uses a timeline-based table for programs and an infographic for platforms.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit